DOCSLIB.ORG

Department of Pathology & Laboratory Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Department of Pathology & Laboratory Medicine F DEPARTMENT OF PATHOLOGY & LABORATORY MEDICINE Residency Procedure Manual Katie Dennis, MD, Residency Program Director Garth Fraga, MD and Sharad Mathur, MD, Associate Residency Program Directors Kim Ates, M.Ed., Residency/Fellowship Program Coordinator Revised October 2016 http://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/300_pathology_2016.pdf 1 KUMC Pathology Residency Manual http://www.kumc.edu/Documents/gme/Web%20Ready%20Version%205.4%20%2012.2015.pdf 2 KUMC Pathology Residency Manual Table of Contents MISSION, GOALS AND PHILOSOPHY .....................................................................................................................5 RESIDENCY EDUCATIONAL PROGRAM .................................................................................................................6 PROGRAM STRUCTURE ........................................................................................................................................ 12 PGY-SPECIFIC GOALS ........................................................................................................................................... 14 GENERAL RESIDENCY GOALS ............................................................................................................................. 20 PRACTICE-BASED LEARNING AND IMPROVEMENT (PBLI) ............................................................................... 22 DIDACTIC SESSIONS AND CONFERENCES ......................................................................................................... 23 RESIDENT SCHOLARLY ACTIVITY........................................................................................................................ 24 PROFESSIONALISM ............................................................................................................................................... 26 ELIGIBILITY AND SELECTION OF RESIDENTS .................................................................................................... 28 GENERAL PROGRAM EVALUATIONS .................................................................................................................. 30 MILESTONES ........................................................................................................................................................... 31 ANNUAL PROGRAM EVALUATIONS ..................................................................................................................... 34 RESIDENT WORK ENVIRONMENT ........................................................................................................................ 39 SUPERVISION OF RESIDENTS .............................................................................................................................. 42 TRANSFER OF CARE (HANDOFF PROTOCOL).................................................................................................... 47 RESIDENT DUTY HOURS AND CALL SCHEDULE ................................................................................................ 48 CALL ASSIGNMENTS ............................................................................................................................................. 50 OUTSIDE ROTATIONS AND MOONLIGHTING ...................................................................................................... 52 RESIDENT FATIGUE ............................................................................................................................................... 54 RESIDENT LEAVE ................................................................................................................................................... 57 CORE COMPETANCY TEACHING AND ASSESSMENT ....................................................................................... 61 ROTATIONS SURGICAL PATHOLOGY ........................................................................................................................................ 62 SURGICAL PATHOLOGY - VAMC .......................................................................................................................... 81 PEDIATRIC SURGICAL PATHOLOGY - CHILDREN'S MERCY HOSPITAL .......................................................... 90 SURGICAL PATHOLOGY TRAINER ..................................................................................................................... 103 MEDICAL RENAL/ELECTRON MICROSCOPY..................................................................................................... 111 CYTOPATHOLOGY ............................................................................................................................................... 115 AUTOPSY SERVICE .............................................................................................................................................. 128 FORENSIC PATHOLOGY ...................................................................................................................................... 141 TRANSFUSION MEDICINE .................................................................................................................................... 145 CLINICAL CHEMISTRY ......................................................................................................................................... 164 HEMATOPATHOLOGY .......................................................................................................................................... 189 WET HEME/FLOW CYTOMETRY .......................................................................................................................... 198 MICROBIOLOGY AND IMMUNOLOGY ................................................................................................................. 210 LABORATORY MANAGEMENT ............................................................................................................................ 220 3 KUMC Pathology Residency Manual INTEGRATED CLINICAL PATHOLOGY - VAMC .................................................................................................. 233 CYTOGENETICS .................................................................................................................................................... 245 MOLECULAR PATHOLOGY .................................................................................................................................. 252 DERMATOPATHOLOGY/NEUROPATHOLOGY ................................................................................................... 260 ANATOMIC PATHOLOGY ELECTIVE ................................................................................................................... 266 CLINICAL PATHOLOGY ELECTIVE ..................................................................................................................... 269 RESEARCH ELECTIVE.......................................................................................................................................... 272 4 KUMC Pathology Residency Manual MISSION, GOALS AND PHILOSOPHY The mission of the Department of Pathology & Laboratory Medicine at the University of Kansas School of Medicine is to provide excellent teaching, research, patient care, and community service to meet the health needs of Kansas and the community at large. Our aim is to provide a supportive work environment in which each individual can excel and pursue avenues that lead to national and international recognition. We will accomplish this by developing mechanisms that make optimal use of our human and financial resources. Within this context the overall goals of our residency training program are to develop a pathologist with the following characteristics: • A pathologist capable of communicating as a medical consultant to other clinicians and to patients, as well as being capable of optimally directing the management of anatomic and clinical laboratory enterprises. The pathologist understands the science and technology of laboratory medicine and assures the quality, clinical appropriateness, and usefulness of the data produced by that laboratory. The pathologist is a clinician first and foremost. • A pathologist who has the skills to recognize, interpret, and communicate pathologic processes in the clinical practice of anatomic pathology. • A pathologist who understands and consults on methods of diagnostic test development, test utilization in the context of both generally applicable as well as patient-specific clinical settings, and assay interpretation in the acute and chronic clinical management of patients. These activities include the pathologist’s role in the development and implementation of integrated medical informatics that optimize patient care. • A pathologist who has the skills to consult in these areas at the broader systems level, and in the various extant healthcare delivery models. • A pathologist who understands the role of research, in its broadest definition, in clinical decision- making, test development, knowledge generation, and continuing education. To accomplish these goals, our program offers a flexible but educationally intensive training program in Anatomic Pathology (AP) and Clinical Pathology (CP, Laboratory Medicine) in order to prepare each of our residents for certification by the American Board of Pathology. A core program provides training that will lead to basic competence in general pathology. Elective opportunities are offered to permit the development of specialty excellence in particular subspecialty
Load more

Recommended publications
  • Educational Paper Ciliopathies
    Eur J Pediatr (2012) 171:1285–1300 DOI 10.1007/s00431-011-1553-z REVIEW Educational paper Ciliopathies Carsten Bergmann Received: 11 June 2011 /Accepted: 3 August 2011 /Published online: 7 September 2011 # The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Cilia are antenna-like organelles found on the (NPHP) . Ivemark syndrome . Meckel syndrome (MKS) . surface of most cells. They transduce molecular signals Joubert syndrome (JBTS) . Bardet–Biedl syndrome (BBS) . and facilitate interactions between cells and their Alstrom syndrome . Short-rib polydactyly syndromes . environment. Ciliary dysfunction has been shown to Jeune syndrome (ATD) . Ellis-van Crefeld syndrome (EVC) . underlie a broad range of overlapping, clinically and Sensenbrenner syndrome . Primary ciliary dyskinesia genetically heterogeneous phenotypes, collectively (Kartagener syndrome) . von Hippel-Lindau (VHL) . termed ciliopathies. Literally, all organs can be affected. Tuberous sclerosis (TSC) . Oligogenic inheritance . Modifier. Frequent cilia-related manifestations are (poly)cystic Mutational load kidney disease, retinal degeneration, situs inversus, cardiac defects, polydactyly, other skeletal abnormalities, and defects of the central and peripheral nervous Introduction system, occurring either isolated or as part of syn- dromes. Characterization of ciliopathies and the decisive Defective cellular organelles such as mitochondria, perox- role of primary cilia in signal transduction and cell isomes, and lysosomes are well-known
    [Show full text]
  • Clinical Classification of Caroli's Disease: an Analysis of 30 Patients
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector DOI:10.1111/hpb.12330 HPB ORIGINAL ARTICLE Clinical classification of Caroli's disease: an analysis of 30 patients Zhong-Xia Wang1,2*, Yong-Gang Li2*, Rui-Lin Wang2, Yong-Wu Li3, Zhi-Yan Li3, Li-Fu Wang2, Hui-Ying Yang2, Yun Zhu2, Yao Wang2, Yun-Feng Bai2, Ting-Ting He2, Xiao-Feng Zhang2 & Xiao-He Xiao1,2 1Department of Graduate School, 301 Hospital, 2Integrative Medical Centre, and 3Imaging Centre, 302 Hospital, Beijing, China Abstract Background: Caroli's disease (CD) is a rare congenital disorder. The early diagnosis of the disease and differentiation of types I and II are of extreme importance to patient survival. This study was designed to review and discuss observations in 30 patients with CD and to clarify the clinical characteristics of the disease. Methods: The demographic and clinical features, laboratory indicators, imaging findings and pathology results for 30 patients with CD were reviewed retrospectively. Results: Caroli's disease can occur at any age. The average age of onset in the study cohort was 24 years. Patients who presented with symptoms before the age of 40 years were more likely to develop type II CD. Approximately one-third of patients presented without positive signs at original diagnosis and most of these patients were found to have type I CD on pathology. Anaemia, leucopoenia and thrombocytopoenia were more frequent in patients with type II than type I CD. Magnetic resonance cholangiopancreatography (MRCP) and computed tomography (CT) examinations were most useful in diagnosing CD.
    [Show full text]
  • Biliary Tract
    2016-06-16 The role of cytology in management of diseases of hepatobiliary ducts • Diagnosis in patients with radiologically/clinically detected lesions • Screening of dysplasia/CIS/cancer in risk groups biliary tract cytology • Preoperative evaluation of the candidates for liver transplantation (Patients with cytological low-grade and high-grade Mehmet Akif Demir, MD dysplasia/adenocarcinoma are currently referred for liver transplantation Sahlgrenska University Hospital in some institutions). Gothenburg Sweden Sarajevo 18th June 2016 • Diagnosis of the benign lesions and infestations False positive findings • majority of false positive cases have a Low sensitivity but high specificity! background of primary sclerosing cholangitis. – lymphoplasmacytic sclerosing pancreatitis and cholangitis, – primary sclerosing cholangitis, – granulomatous disease, – non-specific fibrosis/inflammation – stone disease. False negative findings • Repeat brushing increases the diagnostic yield and should be performed when sampling • Poor sampling biliary strictures with a cytology brush at ERCP. • Lack of diagnostic criteria for dysplasia-carcinoma in situ • Difficulties in recognition of special tumour types – well-differentiated cholangiocarcinoma with tubular architecture • Predictors of positive yield include – gastric foveolar type cholangiocarcinoma with mucin-producing – tumour cells. older age, •Underestimating the significance of the smear background – mass size >1 cm, and – stricture length of >1 cm. •The causes of false negative cytology –sampling
    [Show full text]
  • Unraveling the Genetics of Joubert and Meckel-Gruber Syndromes
    Journal of Pediatric Genetics 3 (2014) 65–78 65 DOI 10.3233/PGE-14090 IOS Press Unraveling the genetics of Joubert and Meckel-Gruber syndromes Katarzyna Szymanska, Verity L. Hartill and Colin A. Johnson∗ Department of Ophthalmology and Neuroscience, University of Leeds, Leeds, UK Received 27 May 2014 Revised 11 July 2014 Accepted 14 July 2014 Abstract. Joubert syndrome (JBTS) and Meckel-Gruber syndrome (MKS) are recessive neurodevelopmental conditions caused by mutations in proteins that are structural or functional components of the primary cilium. In this review, we provide an overview of their clinical diagnosis, management and molecular genetics. Both have variable phenotypes, extreme genetic heterogeneity, and display allelism both with each other and other ciliopathies. Recent advances in genetic technology have significantly improved diagnosis and clinical management of ciliopathy patients, with the delineation of some general genotype-phenotype correlations. We highlight those that are most relevant for clinical practice, including the correlation between TMEM67 mutations and the JBTS variant phenotype of COACH syndrome. The subcellular localization of the known MKS and JBTS proteins is now well-described, and we discuss some of the contemporary ideas about ciliopathy disease pathogenesis. Most JBTS and MKS proteins localize to a discrete ciliary compartment called the transition zone, and act as structural components of the so-called “ciliary gate” to regulate the ciliary trafficking of cargo proteins or lipids. Cargo proteins include enzymes and transmembrane proteins that mediate intracellular signaling. The disruption of transition zone function may contribute to the ciliopathy phenotype by altering the composition of the ciliary membrane or axoneme, with impacts on essential developmental signaling including the Wnt and Shh pathways as well as the regulation of secondary messengers such as inositol-1,4,5-trisphosphate (InsP3) and cyclic adenosine monophosphate (cAMP).
    [Show full text]
  • Research Day 2021 Program
    Western Michigan University ScholarWorks at WMU Research Day WMU Homer Stryker M.D. School of Medicine 2021 Research Day 2021 Program Western Michigan University Homer Stryker M.D. School of Medicine Follow this and additional works at: https://scholarworks.wmich.edu/medicine_research_day Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons WMU ScholarWorks Citation Homer Stryker M.D. School of Medicine, Western Michigan University, "Research Day 2021 Program" (2021). Research Day. 298. https://scholarworks.wmich.edu/medicine_research_day/298 This Abstract is brought to you for free and open access by the WMU Homer Stryker M.D. School of Medicine at ScholarWorks at WMU. It has been accepted for inclusion in Research Day by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. th 38 Annual Kalamazoo Community Medical and Health Sciences Virtual Research Day Wednesday, April 21, 2021 8:00 a.m. – 12:00 p.m. TABLE OF CONTENTS INTRODUCTION ........................................................................................................... 4 KEYNOTE SPEAKER.................................................................................................... 6 SCHEDULE ..................................................................................................................... 7 ORAL PRESENTATIONS ............................................................................................. 8 ORAL ABSTRACTS ....................................................................................................
    [Show full text]
  • ARPKD): Kidney-Related and Non-Kidney-Related Phenotypes
    Pediatr Nephrol (2014) 29:1915–1925 DOI 10.1007/s00467-013-2634-1 EDUCATIONAL REVIEW Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes Rainer Büscher & Anja K. Büscher & Stefanie Weber & Julia Mohr & Bianca Hegen & Udo Vester & Peter F. Hoyer Received: 26 April 2013 /Revised: 5 September 2013 /Accepted: 6 September 2013 /Published online: 10 October 2013 # IPNA 2013 Abstract Autosomal recessive polycystic kidney disease disease. In this review we focus on common and uncommon (ARPKD), although less frequent than the dominant form, is kidney-related and non-kidney-related phenotypes. Clinical a common, inherited ciliopathy of childhood that is caused by management of ARPKD patients should include consideration mutations in the PKHD1-gene on chromosome 6. The charac- of potential problems related to these manifestations. teristic dilatation of the renal collecting ducts starts in utero and can present at any stage from infancy to adulthood. Renal Keywords ARPKD . Extrarenal manifestation . Children . insufficiency may already begin in utero and may lead to early Hepatic fibrosis . Portal hypertension . Caroli’ssyndrome abortion or oligohydramnios and lung hypoplasia in the new- born. However, there are also affected children who have no evidence of renal dysfunction in utero and who are born with Introduction normal renal function. Up to 30 % of patients die in the perinatal period, and those surviving the neonatal period reach Autosomal recessive polycystic kidney disease (ARPKD) be- end stage renal disease (ESRD) in infancy, early childhood or longs to the family of cilia-related disorders and is an important adolescence. In contrast, some affected patients have been inherited disease with distinct clinical features and genetics.
    [Show full text]
  • Targeted Exome Sequencing Provided Comprehensive Genetic Diagnosis of Congenital Anomalies of the Kidney and Urinary Tract
    Journal of Clinical Medicine Article Targeted Exome Sequencing Provided Comprehensive Genetic Diagnosis of Congenital Anomalies of the Kidney and Urinary Tract 1,2, 3,4, 3 1,5 Yo Han Ahn y, Chung Lee y, Nayoung K. D. Kim , Eujin Park , Hee Gyung Kang 1,2,6,* , Il-Soo Ha 1,2,6, Woong-Yang Park 3,4,7 and Hae Il Cheong 1,2,6 1 Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Korea; [email protected] (Y.H.A.); [email protected] (E.P.); [email protected] (I.-S.H.); [email protected] (H.I.C.) 2 Department of Pediatrics, Seoul National University Children’s Hospital, Seoul 03080, Korea 3 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea; [email protected] (C.L.); [email protected] (N.K.D.K.); [email protected] (W.-Y.P.) 4 Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul 06351, Korea 5 Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul 07441, Korea 6 Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 03080, Korea 7 Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, Korea * Correspondence: [email protected] These authors equally contributed to this article. y Received: 31 January 2020; Accepted: 8 March 2020; Published: 10 March 2020 Abstract: Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in children.
    [Show full text]
  • Article Case Report Congenital Hepatic Fibrosis
    Article Case report Congenital hepatic fibrosis: case report and review of literature Brahim El Hasbaoui, Zainab Rifai, Salahiddine Saghir, Anas Ayad, Najat Lamalmi, Rachid Abilkassem, Aomar Agadr Corresponding author: Zainab Rifai, Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco. [email protected] Received: 19 Jan 2021 - Accepted: 03 Feb 2021 - Published: 18 Feb 2021 Keywords: Fibrosis, hyper-transaminasemia, cholestasis, ciliopathy, case report Copyright: Brahim El Hasbaoui et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cite this article: Brahim El Hasbaoui et al. Congenital hepatic fibrosis: case report and review of literature. Pan African Medical Journal. 2021;38(188). 10.11604/pamj.2021.38.188.27941 Available online at: https://www.panafrican-med-journal.com//content/article/38/188/full Congenital hepatic fibrosis: case report and review &Corresponding author of literature Zainab Rifai, Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, Brahim El Hasbaoui1, Zainab Rifai2,&, Salahiddine University Mohammed V, Rabat, Morocco Saghir1, Anas Ayad1, Najat Lamalmi3, Rachid 1 1 Abilkassem , Aomar Agadr 1Department of Pediatrics, Military Teaching Hospital Mohammed V, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco, 2Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco, 3Department of Histopathologic, Avicenne Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco Article characterized histologically by defective Abstract remodeling of the ductal plate (DPM).
    [Show full text]
  • Management of Choledochal Cysts
    REVIEW CURRENT OPINION Management of choledochal cysts Sean M. Ronnekleiv-Kelly, Kevin C. Soares, Aslam Ejaz, and Timothy M. Pawlik Purpose of review Historically, surgical treatment of choledochal cyst consisted of cyst enterostomy. However, incomplete cyst excision can result in recurrent symptoms and malignant transformation within the cyst remnant. 09/20/2020 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3pxNPODIEKBpIl4WIJuUC3wZcoMyoyOwWjpQO3AzJmNqjsWy7MP1HEA== by https://journals.lww.com/co-gastroenterology from Downloaded Downloaded Accordingly, management of choledochal cyst now includes complete cyst excision whenever possible. We provide a review detailing the up to date management of choledochal cysts. We describe choledochal from cyst-type specific surgical approaches, the impact of minimally invasive surgery in choledochal cyst https://journals.lww.com/co-gastroenterology therapy, and long-term sequelae of choledochal cyst management. Recent findings Treatment of choledochal cyst aims to avoid the numerous hepatic, pancreatic, or biliary complications that may occur. More recently, minimally invasive approaches are being used for the treatment of choledochal cyst with acceptable morbidity and mortality. Moreover, long-term follow up of choledochal cyst patients after resection has demonstrated that although the risk of biliary malignancy is significantly decreased after choledochal cyst resection, these patients may remain at a slightly increased risk of biliary malignancy by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3pxNPODIEKBpIl4WIJuUC3wZcoMyoyOwWjpQO3AzJmNqjsWy7MP1HEA==
    [Show full text]
  • Evolving Concepts in Human Renal Dysplasia
    DISEASE OF THE MONTH J Am Soc Nephrol 15: 998–1007, 2004 EBERHARD RITZ, FEATURE EDITOR Evolving Concepts in Human Renal Dysplasia ADRIAN S. WOOLF, KAREN L. PRICE, PETER J. SCAMBLER, and PAUL J.D. WINYARD Nephro-Urology and Molecular Medicine Units, Institute of Child Health, University College London, London, United Kingdom Abstract. Human renal dysplasia is a collection of disorders in correlating with perturbed cell turnover and maturation. Mu- which kidneys begin to form but then fail to differentiate into tations of nephrogenesis genes have been defined in multiorgan normal nephrons and collecting ducts. Dysplasia is the princi- dysmorphic disorders in which renal dysplasia can feature, pal cause of childhood end-stage renal failure. Two main including Fraser, renal cysts and diabetes, and Kallmann syn- theories have been considered in its pathogenesis: A primary dromes. Here, it is possible to begin to understand the normal failure of ureteric bud activity and a disruption produced by nephrogenic function of the wild-type proteins and understand fetal urinary flow impairment. Recent studies have docu- how mutations might cause aberrant organogenesis. mented deregulation of gene expression in human dysplasia, Congenital anomalies of the kidney and urinary tract and the main renal pathology is renal dysplasia (RD). In her (CAKUT) account for one third of all anomalies detected by landmark book Normal and Abnormal Development of the routine fetal ultrasonography (1). A recent UK audit of child- Kidney published in 1972 (7), Edith Potter emphasized that one hood end-stage renal failure reported that CAKUT was the must understand normal development to generate realistic hy- cause in ~40% of 882 individuals (2).
    [Show full text]
  • Histone Deacetylase 6 Represents a Novel Drug Target in the Oncogenic Hedgehog Signaling Pathway
    Aus dem Institut für Molekularbiologie und Tumorforschung Geschäftsführender Direktor: Prof. Dr. Rolf Müller des Fachbereichs Medizin der Philipps-Universität Marburg Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway Inaugural- Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften dem Fachbereich Medizin der Philipps-Universität Marburg vorgelegt von Dhanyamraju Pavan Kumar aus Secunderabad, Indien Marburg-2017 Angenommen vom Fachbereich Medizin der Philipps Universität Marburg am:3/11/2017 Gedruckt mit der Genehmigung des Fachbereichs Dekan: Prof. Dr. Helmut Schäfer Referent: PD. Dr. Matthias Lauth Korreferent: Prof. Dr. Elke Pogge von Strandmann Table of Contents 1. Summary……………………………………………………………………………...1 1. Zussamenfassung …………………………………………………………....……….2 2. Introduction………………………………………………………………………......3 2.1 The Hedgehog signalling pathway…………………………………………………3 2.2 The Mechanism of Hedgehog signal transduction…………………………………5 2.3 Ptch1 a tumor suppressor gene…………………………………………………....10 2.4 Primary cilium and Hedgehog signalling.………………….………………….….11 2.5 Histone deacetylases (HDACs)………………………………………………...…15 2.6 Classification of Histone deacetylases……………………………………………16 2.7 Histone deacetylase 6……………………………………………………….….…17 2.8 Regulation of Ciliogenesis by HDAC6…………………………………………...20 2.9 Hedgehog signalling and Cancer………………………………………………….22 2.10 Hedgehog signalling Type-I- Mutation driven-ligand independent………….….22 2.11 Hedgehog signalling Type-II-Autocrine-ligand dependent………………….….23
    [Show full text]
  • Abstracts from the 51St European Society of Human Genetics Conference: Electronic Posters
    European Journal of Human Genetics (2019) 27:870–1041 https://doi.org/10.1038/s41431-019-0408-3 MEETING ABSTRACTS Abstracts from the 51st European Society of Human Genetics Conference: Electronic Posters © European Society of Human Genetics 2019 June 16–19, 2018, Fiera Milano Congressi, Milan Italy Sponsorship: Publication of this supplement was sponsored by the European Society of Human Genetics. All content was reviewed and approved by the ESHG Scientific Programme Committee, which held full responsibility for the abstract selections. Disclosure Information: In order to help readers form their own judgments of potential bias in published abstracts, authors are asked to declare any competing financial interests. Contributions of up to EUR 10 000.- (Ten thousand Euros, or equivalent value in kind) per year per company are considered "Modest". Contributions above EUR 10 000.- per year are considered "Significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal Genetics then compared this data to de novo cases where research based PO studies were completed (N=57) in NY. E-P01.01 Results: MFSIQ (66.4) for familial deletions was Parent of origin in familial 22q11.2 deletions impacts full statistically lower (p = .01) than for de novo deletions scale intelligence quotient scores (N=399, MFSIQ=76.2). MFSIQ for children with mater- nally inherited deletions (63.7) was statistically lower D. E. McGinn1,2, M. Unolt3,4, T. B. Crowley1, B. S. Emanuel1,5, (p = .03) than for paternally inherited deletions (72.0). As E. H. Zackai1,5, E. Moss1, B. Morrow6, B. Nowakowska7,J. compared with the NY cohort where the MFSIQ for Vermeesch8, A.
    [Show full text]